InvestorsHub Logo
Followers 57
Posts 5703
Boards Moderated 0
Alias Born 12/13/2004

Re: volgoat post# 176495

Thursday, 05/15/2014 10:55:32 AM

Thursday, May 15, 2014 10:55:32 AM

Post# of 346551
Glad Jazz is on our side! He is probably correct about both Dendreon and Northwest benefiting from Bavi! Dendreon's Provenge needs a boost to capture the market. NWBO's Direct approach should benefit from a Bavi combination...as should its vaccine. PPHM has listed Provenge as a potential preclinical trial combination. And Northwest would probably also be an interesting partner.

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News